Drugs / Universal STAR-T Cell Injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07523100 | Apr 2026 → Apr 2027 expected | multiple sclerosis | Daishi Tian | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Universal STAR-T Cell Injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07523100 ↗ |
| Modality | Cell therapy | “Universal STAR-T cell injection” NCT07523100 ↗ |
| Route | Other | “cell infusion” NCT07523100 ↗ |